We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+14.79%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.18B
AUM Growth
+$203M
Cap. Flow
-$31.5M
Cap. Flow %
-1.45%
Top 10 Hldgs %
35.11%
Holding
404
New
36
Increased
94
Reduced
108
Closed
38

Top Buys

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$32.8M
2
PFE icon
Pfizer
PFE
+$24.5M
3
AXP icon
American Express
AXP
+$24.2M
4
EPAM icon
EPAM Systems
EPAM
+$16.4M
5
MRK icon
Merck
MRK
+$16.1M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$24.3M
2
EHC icon
Encompass Health
EHC
+$24M
3
USB icon
US Bancorp
USB
+$21.9M
4
EG icon
Everest Group
EG
+$18.7M
5
ETN icon
Eaton
ETN
+$17.7M

Sector Composition

Rank Sector Weight
1 Technology 33.85%
2 Healthcare 14.97%
3 Consumer Discretionary 12.67%
4 Financials 10.15%
5 Industrials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBT icon
326
Cabot Corp
CBT
$4.46B
$7K ﹤0.01%
130
CMI icon
327
Cummins
CMI
$87.4B
$7K ﹤0.01%
31
GIS icon
328
General Mills
GIS
$19.9B
$7K ﹤0.01%
108
HSTM icon
329
HealthStream
HSTM
$859M
$7K ﹤0.01%
270
OMC icon
330
Omnicom Group
OMC
$23.2B
$7K ﹤0.01%
93
SANM icon
331
Sanmina
SANM
$10.7B
$7K ﹤0.01%
160
BCOV
332
DELISTED
Brightcove, Inc.
BCOV
$7K ﹤0.01%
710
BEAM icon
333
Beam Therapeutics
BEAM
$2.82B
$6K ﹤0.01%
70
CTVA icon
334
Corteva
CTVA
$51B
$6K ﹤0.01%
133
HALO icon
335
Halozyme
HALO
$12.2B
$6K ﹤0.01%
150
LVS icon
336
Las Vegas Sands
LVS
$29.4B
$6K ﹤0.01%
150
DNLI icon
337
Denali Therapeutics
DNLI
$4B
$5K ﹤0.01%
110
FATE icon
338
Fate Therapeutics
FATE
$322M
$5K ﹤0.01%
90
GPRO icon
339
GoPro
GPRO
$121M
$5K ﹤0.01%
520
IMXI icon
340
International Money Express
IMXI
$356M
$5K ﹤0.01%
330
VTLE
341
DELISTED
Vital Energy
VTLE
$5K ﹤0.01%
90
ACAD icon
342
Acadia Pharmaceuticals
ACAD
$5.06B
$4K ﹤0.01%
160
ALKS icon
343
Alkermes
ALKS
$8.29B
$4K ﹤0.01%
180
APLS
344
DELISTED
Apellis Pharmaceuticals
APLS
$4K ﹤0.01%
80
HSII
345
DELISTED
Heidrick & Struggles
HSII
$4K ﹤0.01%
90
INSM icon
346
Insmed
INSM
$29.4B
$4K ﹤0.01%
130
TWST icon
347
Twist Bioscience
TWST
$7.83B
$4K ﹤0.01%
50
CDNA icon
348
CareDx
CDNA
$2.44B
$3K ﹤0.01%
60
FOLD
349
DELISTED
Amicus Therapeutics
FOLD
$3K ﹤0.01%
300
IRWD icon
350
Ironwood Pharmaceuticals
IRWD
$669M
$3K ﹤0.01%
230

Similar funds

Smith Group Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Smith Group Asset Management held 404 positions worth $2.18B, up 10% from $1.97B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Smith Group Asset Management's Q4 2021 filing shows 36 new, 94 increased, 108 reduced and 38 closed positions. Its largest new stake was AutoNation: 130,907 shares worth $15.3M. The largest sale was PayPal, an estimated $24.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Smith Group Asset Management's largest Q4 2021 buy was AutoNation: 130,907 shares worth $15.3M.
  • Smith Group Asset Management added most to Zebra Technologies in Q4 2021, an estimated $32.8M increase.
  • Smith Group Asset Management's biggest Q4 2021 reduction was US Bancorp, cutting an estimated $21.9M.
  • Smith Group Asset Management fully exited PayPal in Q4 2021, selling an estimated $24.3M.
  • Smith Group Asset Management's ten largest holdings make up 35% of its $2.18B portfolio in Q4 2021.
  • Smith Group Asset Management opened 36 new positions and closed 38 in Q4 2021.
  • Smith Group Asset Management's portfolio value rose 10% quarter-over-quarter to $2.18B.

Based on Smith Group Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.